Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

17.4%

36 terminated/withdrawn out of 207 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

12%

25 trials in Phase 3/4

Results Transparency

50%

54 of 108 completed trials have results

Key Signals

27 recruiting54 with results18 terminated18 withdrawn

Enrollment Performance

Analytics

N/A

125(68.3%)

Phase 4

17(9.3%)

Phase 2

15(8.2%)

Phase 1

14(7.7%)

Phase 3

8(4.4%)

Early Phase 1

4(2.2%)

183Total

N/A(125)

Phase 4(17)

Phase 2(15)

Phase 1(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (207)

Showing 20 of 207 trials

NCT07645742Not ApplicableNot Yet Recruiting

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Role: lead

NCT06439979Not ApplicableRecruiting

Rural Adult and Youth Sun Protection Study

Role: collaborator

NCT07625189Recruiting

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

Role: lead

NCT04376034Phase 3Completed

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

Role: lead

NCT06957444Not ApplicableEnrolling By Invitation

Rate of Allergic Contact Dermatitis and Cosmetic Outcomes

Role: lead

NCT07162935Not ApplicableRecruiting

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)

Role: collaborator

NCT07560046Phase 4Not Yet Recruiting

Combating Related Epidemics in HCV

Role: collaborator

NCT05156437Phase 4Terminated

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

Role: lead

NCT04466865Not ApplicableCompleted

A Communication Tool to Assist Older Adults Facing Dialysis Choices

Role: collaborator

NCT06820164Phase 1Recruiting

Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride

Role: lead

NCT06023459Phase 3Completed

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Role: collaborator

NCT05535894Completed

Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

Role: lead

NCT04922723Phase 1Active Not Recruiting

Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma

Role: lead

NCT05507151Active Not Recruiting

Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Role: lead

NCT06923488Phase 1Recruiting

Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes

Role: lead

NCT07401277Phase 1Recruiting

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

Role: lead

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT06808503Not ApplicableRecruiting

NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics

Role: lead

NCT06237868Not ApplicableRecruiting

rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

Role: lead

NCT04578249Not ApplicableRecruiting

Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH

Role: lead